RhumbLine Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-25,183
Closed -$15.6K 4367
2024
Q2
$15.6K Sell
25,183
-102,240
-80% -$86.4K ﹤0.01% 3907
2024
Q1
$327K Buy
127,423
+3,747
+3% +$9.15K ﹤0.01% 2937
2023
Q4
$252K Sell
123,676
-545
-0.4% -$995 ﹤0.01% 3070
2023
Q3
$214K Sell
124,221
-5,832
-4% -$10.4K ﹤0.01% 3128
2023
Q2
$254K Buy
+130,053
New +$305K ﹤0.01% 3109
2022
Q2
Sell
-56,865
Closed -$234K 3266
2022
Q1
$234K Buy
56,865
+1,170
+2% +$6.2K ﹤0.01% 2718
2021
Q4
$716K Buy
55,695
+3,566
+7% +$39.5K ﹤0.01% 2353
2021
Q3
$563K Buy
52,129
+1,900
+4% +$17.3K ﹤0.01% 2489
2021
Q2
$459K Buy
50,229
+13,837
+38% +$128K ﹤0.01% 2600
2021
Q1
$343K Sell
36,392
-2,100
-5% -$28.9K ﹤0.01% 2650
2020
Q4
$152K Buy
38,492
+7,072
+23% +$21.4K ﹤0.01% 2900
2020
Q3
$83K Sell
31,420
-5,396
-15% -$20K ﹤0.01% 2903
2020
Q2
$244K Buy
36,816
+6,563
+22% +$44.2K ﹤0.01% 2675
2020
Q1
$176K Buy
30,253
+1,950
+7% +$16.4K ﹤0.01% 2630
2019
Q4
$254K Buy
28,303
+250
+0.9% +$2.08K ﹤0.01% 2672
2019
Q3
$242K Buy
28,053
+2,774
+11% +$28K ﹤0.01% 2679
2019
Q2
$282K Buy
+25,279
New +$289K ﹤0.01% 2631

Other funds holding GRTS

RhumbLine Advisers's GRTS Position: Q3 2024 in Review

RhumbLine Advisers sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 25,183 shares — an estimated $15.6K sold.

RhumbLine Advisers first reported a position in GRTS in Q2 2019 and held it in 17 quarters. The position peaked at $716K in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • RhumbLine Advisers reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 25,183 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $15.6K.
  • RhumbLine Advisers first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 17 quarters.
  • RhumbLine Advisers's Gritstone bio, Inc. Common Stock position peaked at $716K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.